These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 9704449)

  • 21. The future of monoclonal antibody engineering.
    Renner C; Hartmann F; Pfreundschuh M
    Ann Hematol; 2001; 80 Suppl 3():B127-9. PubMed ID: 11757694
    [No Abstract]   [Full Text] [Related]  

  • 22. Engineering antibodies for therapy.
    Adair JR
    Immunol Rev; 1992 Dec; 130():5-40. PubMed ID: 1286872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radioimmunotherapy with engineered antibodies.
    Russeva MG; Adams GP
    Expert Opin Biol Ther; 2004 Feb; 4(2):217-31. PubMed ID: 14998779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of the primary antibody repertoire.
    Alt FW; Blackwell TK; Yancopoulos GD
    Science; 1987 Nov; 238(4830):1079-87. PubMed ID: 3317825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B-cell superantigens: implications for selection of the human antibody repertoire.
    Zouali M
    Immunol Today; 1995 Aug; 16(8):399-405. PubMed ID: 7546197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The humoral immune response against blood group antigens at the molecular level.
    Ouwehand WH; Bye JM; Gorick BD; Marks JD; Timmers E; Griffin HM; Finnern R; Hughes-Jones N
    Vox Sang; 1994; 67 Suppl 3():7-12. PubMed ID: 7975514
    [No Abstract]   [Full Text] [Related]  

  • 27. Phage display technology in antibody engineering: design of phagemid vectors and in vitro maturation systems.
    Söderlind E; Simonsson AC; Borrebaeck CA
    Immunol Rev; 1992 Dec; 130():109-24. PubMed ID: 1286867
    [No Abstract]   [Full Text] [Related]  

  • 28. Generation of humanized monoclonal antibodies by 'best fit' framework selection and recombinant polymerase chain reaction.
    Lewis AP; Crowe JS
    Year Immunol; 1993; 7():110-8. PubMed ID: 8372500
    [No Abstract]   [Full Text] [Related]  

  • 29. [Transgenesis and humanization of murine antibodies].
    Cogné M; Duchez S; Pascal V
    Med Sci (Paris); 2009 Dec; 25(12):1149-54. PubMed ID: 20035696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tailor-made antibody therapeutics.
    Chowdhury PS; Wu H
    Methods; 2005 May; 36(1):11-24. PubMed ID: 15848071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody engineering via genetic engineering of the mouse: XenoMouse strains are a vehicle for the facile generation of therapeutic human monoclonal antibodies.
    Green LL
    J Immunol Methods; 1999 Dec; 231(1-2):11-23. PubMed ID: 10648924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Universal antibody libraries on phage and bacteria.
    Little M; Breitling F; Dübel S; Fuchs P; Braunagel M; Seehaus T; Klewinghaus I
    Year Immunol; 1993; 7():50-5. PubMed ID: 8372512
    [No Abstract]   [Full Text] [Related]  

  • 33. Mouse variable-region gene families: complexity, polymorphism and use in non-autoimmune responses.
    Kofler R; Geley S; Kofler H; Helmberg A
    Immunol Rev; 1992 Aug; 128():5-21. PubMed ID: 1427923
    [No Abstract]   [Full Text] [Related]  

  • 34. Man-made antibodies.
    Winter G; Milstein C
    Nature; 1991 Jan; 349(6307):293-9. PubMed ID: 1987490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
    Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
    Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The biotechnology and applications of antibody engineering.
    Rapley R
    Mol Biotechnol; 1995 Apr; 3(2):139-54. PubMed ID: 7620975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B cells in autoimmune diseases: insights from analyses of immunoglobulin variable (Ig V) gene usage.
    Foreman AL; Van de Water J; Gougeon ML; Gershwin ME
    Autoimmun Rev; 2007 Jun; 6(6):387-401. PubMed ID: 17537385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody engineering at the millennium.
    Gavilondo JV; Larrick JW
    Biotechniques; 2000 Jul; 29(1):128-32, 134-6, 138 passim. PubMed ID: 10907088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Somatic origin of T-cell epitopes within antibody variable regions: significance to monoclonal therapy and genesis of systemic autoimmune disease.
    Wysocki LJ; Zhang X; Smith DS; Snyder CM; Bonorino C
    Immunol Rev; 1998 Apr; 162():233-46. PubMed ID: 9602368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production of a diverse repertoire of human antibodies in genetically engineered mice.
    Ishida I; Yoshida H; Tomizuka K
    Microbiol Immunol; 1998; 42(3):143-50. PubMed ID: 9570278
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.